Literature DB >> 10490434

Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis.

N Washington1, P J Spensley, C A Smith, M Parker, D Bush, S J Jackson, L Kapila, T Stephenson, C Washington.   

Abstract

OBJECTIVES: Oesophageal pH monitoring is the gold standard technique for the detection of gastro-oesophageal reflux in adults and children. A standard parameter used to define "abnormal" reflux is the percentage of recording time for which the gastric pH is < 4. This study investigated the relevance of this measure in infants on regular milk feeds whose gastric contents and refluxate will be neutral for most of the recording time.
METHODS: Simultaneous oesophageal and gastric pH monitoring was carried out on all infants who were milk fed exclusively and admitted to hospital for suspected gastro-oesophageal reflux. In vitro studies were performed to establish the buffering capacities of the fruit juice, Dioralyte (a glucose electrolyte solution), breast milk, and milk formula feeds available on the paediatric wards.
RESULTS: Complete sets of data were obtained from 30 babies with a mean age of 4 months. Gastric pH was </= 4 for a mean (SEM) of 42.4 (4.9)% of the recording time. The mean (SEM) percentage time that oesophageal pH was < 4 for the total recording period was 6.89 (0.92)%. Recalculation of the percentage of time that the gastric pH was > 4 increased this value to 17.81 (2. 46)%. Using a cut off point of 10%, 11 of the 30 babies would have been diagnosed positive for reflux using the conventional method; however, recalculation by ignoring the time for which gastric pH was high doubled this to 22 positive for reflux.
CONCLUSION: Combined oesophageal and gastric pH monitoring greatly increases the number of positive results from tests in infants on regular milk feeds.

Entities:  

Mesh:

Year:  1999        PMID: 10490434      PMCID: PMC1718105          DOI: 10.1136/adc.81.4.309

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Infant apnea and gastroesophageal reflux.

Authors:  H Gomes; P Lallemand
Journal:  Pediatr Radiol       Date:  1992

2.  Area under pH 4: advantages of a new parameter in the interpretation of esophageal pH monitoring data in infants.

Authors:  Y Vandenplas; A Franckx-Goossens; M Pipeleers-Marichal; M P Derde; L Sacré-Smits
Journal:  J Pediatr Gastroenterol Nutr       Date:  1989-07       Impact factor: 2.839

3.  Gastro-oesophageal reflux and gastric emptying of liquids in paediatric patients.

Authors:  J Guillet; S Wynchank; E Christophe; B Basse-Cathalinat; D Ducassou; P Blanquet
Journal:  Int J Nucl Med Biol       Date:  1984

4.  Dietary caloric density and osmolality influence gastroesophageal reflux in infants.

Authors:  J L Sutphen; V L Dillard
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

5.  Gastric emptying with gastro-oesophageal reflux.

Authors:  C Di Lorenzo; A Piepsz; H Ham; S Cadranel
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

6.  Ambulatory esophageal pH monitoring in children as an indicator for surgery.

Authors:  D F Evans; J Haynes; J A Jones; M J Stower; L Kapila
Journal:  J Pediatr Surg       Date:  1986-03       Impact factor: 2.545

7.  Paediatric gastro-oesophageal reflux: prognostic indicators from pH monitoring.

Authors:  K Varty; D Evans; L Kapila
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

  7 in total
  10 in total

1.  Simultaneous monitoring of gastric and oesophageal pH reveals limitations of conventional oesophageal pH monitoring in milk fed infants.

Authors:  D J Mitchell; B G McClure; T R Tubman
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

Review 2.  Can pH monitoring reliably detect gastro-oesophageal reflux in preterm infants?

Authors:  L Grant; D Cochran
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

3.  Multipoint measurement of intragastric pH in healthy preterm infants.

Authors:  T I Omari; G P Davidson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-11       Impact factor: 5.747

4.  Risk management, or just a different risk?

Authors:  Y Freer; A Lyon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-02-07       Impact factor: 5.747

5.  Human milk triggers coagulation via tissue factor-exposing extracellular vesicles.

Authors:  Yong Hu; Lena Hell; Ruth Anna Kendlbacher; Najat Hajji; Chi Hau; Annemieke van Dam; René J Berckmans; Lukas Wisgrill; Cihan Ay; Ingrid Pabinger; Alain Brisson; Andreas Repa; Rienk Nieuwland; Johannes Thaler
Journal:  Blood Adv       Date:  2020-12-22

Review 6.  Diagnosis of gastroesophageal reflux disease in infants.

Authors:  Frankie B Fike; Vincent E Mortellaro; Janine N Pettiford; Daniel J Ostlie; Shawn D St Peter
Journal:  Pediatr Surg Int       Date:  2011-04-06       Impact factor: 1.827

Review 7.  Esophageal impedance monitoring for gastroesophageal reflux.

Authors:  Hayat M Mousa; Rachel Rosen; Frederick W Woodley; Marina Orsi; Daneila Armas; Christophe Faure; John Fortunato; Judith O'connor; Beth Skaggs; Samuel Nurko
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-02       Impact factor: 2.839

8.  Fundoplication in neonates and infants with primary gastroesophageal reflux.

Authors:  Byung Geon Yoo; Hea Kyoung Yang; Yeoun Joo Lee; Shin Yun Byun; Hae Young Kim; Jae Hong Park
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-06-30

9.  Microbiota diversity and stability of the preterm neonatal ileum and colon of two infants.

Authors:  Eoin Barrett; Caitriona M Guinane; C Anthony Ryan; Eugene M Dempsey; Brendan P Murphy; Paul W O'Toole; Gerald F Fitzgerald; Paul D Cotter; R Paul Ross; Catherine Stanton
Journal:  Microbiologyopen       Date:  2013-01-24       Impact factor: 3.139

10.  A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.

Authors:  Raches Ella; Radhika Bobba; Sanjay Muralidhar; Sudhir Babji; Krishna Mohan Vadrevu; Maharaj Kishan Bhan
Journal:  Hum Vaccin Immunother       Date:  2018-04-12       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.